Latest Articlesddd
The News Prohost Was Waiting for to Post Its Special Letter Prohost has one eye on …
Rhythm Pharmaceuticals From Rhythm Pharmaceuticals (RYTM) we learned that positive, top-line results from two pivotal Phase 3 …
What Have We Learned from the Market's Recent Stock Moves? Well. Did we learn anything from …
In This Column Every day thousands of press releases are issued about biotechnology and pharmaceutical firms. …
Prohost has just finished a very hard task; evaluating its best picks from the biotechnology and …
Nektar Therapeutics We believe that Nektar Therapeutics (NKTR) is undervalued. We base this on the firm’s technological capability. …
RegenxBio License Agreement with Pfizer RegenxBio (RGNX) announced a license agreement with Pfizer (PFE). Under the terms of …
Amgen Contrary to our expectations Amgen’s (AMGN) shares declined more than 10% in 2019, instead of rallying. …
Gilead Sciences Activities There is no doubt that Gilead Sciences (GILD) is doing whatever it takes to expand, …
Halozyme and argenx Collaboration argenx (ARGX) dosed the first subject in phase 1 clinical trial for the …
Seattle Genetics Stock Rallied Seattle Genetics (SGEN) financial results started with Clay Siegall, Ph.D., President and …
CiRA, Takeda & T-CiRA Less than five years ago the Center for iPS Cell Research and Application …
Gilead and Galapagos Global Research Collaboration Gilead Sciences (GILD) and Galapagos NV (GLPG) entered into a 10-year global …
Exelixis is Expanding Cohorts for COSMIC-021, the Phase 1b Trial for Cabozantinib From Exelixis (EXEL) we …
Illumina Stock Dropped Following Their Preliminary Revenue Announcement Illumina (ILMN) stock dropped 16% following the firm's announcement …
The EC Granted Conditional Approval for Regeneron and Sanofi Product Libtayo for CSCC The European Commission (EC) …
Sangamo and Pfizer Gene Therapy SB-525 Resulted in a Sustained Increase in Factor VIII Levels in …
Gilead to File NDA for Filgotinib for Rheumatoid Arthritis Meeting with the U.S. Food and Drug …
Small Biotech Firms That Can Become Top-Tier Biotech Giants We Start With... Abeona Therapeutics Abeona Therapeutics …
ImmunoGen’s Big Internal Changes ImmunoGen (IMGN) announced a radical impacting decision following the completion of an in-depth …
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. Accept Privacy policy
